FT-01

N/A

Report date: 2026/05/20 10:52:39
NME

Base Information

Drug NameFT-01
Drug Alias NameFT-01
ClassificationSmall molecules
Mechanisms of ActionCytoplasmic tyrosine-protein kinase BMX inhibitorsAnticancer protein kinase inhibitors
TargetsCytoplasmic tyrosine-protein kinase BMX
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFekra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFekra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A